The success of Viagra initially sparked a period of growth for major pharmaceutical companies, nevertheless recent changes present a complicated picture for shareholders. Off-patent competitors are eating into revenue, https://nanabcxy306520.mpeblog.com/74347918/the-blue-pill-and-big-pharma-a-risky-investment